LIFE SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2020-06-01 南风

请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？

81 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2024-02-20 ms4000000100009364 来自重庆

2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗

28 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2023-12-04 ms4000000245921040 来自北京

杂志编辑跑路了吗？已经1周多了还是submitted???

25 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2023-08-14 氢弹来自四川省

肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？

40 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2023-03-27 wenan666 来自江西省

我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？

40 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2021-05-15 ms8000000153481283

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：医学;药学;心血管药理学
经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~

61 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2021-01-03 1e0cf3e5m18(暂无匿称)

审稿速度:1.0 | 投稿命中率:75.0
经验分享：大水刊，黑名单杂志

443 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2020-08-12 二胖十一小同学

审稿速度:2.0 | 投稿命中率:50.0
经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？

113 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2020-03-28 14759364m80(暂无昵称)

请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表:
意思是对于你的文章要不要外审，编辑还在考虑中

jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中

87 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=600991, encodeId=d84d600991c3, content=请问under review是指已经找到审稿人了吗？还是依然在编辑那呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9fWIeibNYic76ibSvVO7ibGnBxl3RuJ3XoPQ9icVxc5neKh7e8tBzPyKF75Depicw4xdvZsWtsnt3W1JA/132, createdBy=d08f5307880, createdName=南风, createdTime=Mon Jun 01 10:36:13 CST 2020, time=2020-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2172940, encodeId=cefe21e29400a, content=杂志编辑跑路了吗？已经1周多了还是submitted???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Mon Dec 04 22:21:12 CST 2023, time=2023-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152774, encodeId=03202152e74d3, content=肿瘤的基础研究。三个审稿人，两个意见很好给了小修，另外一个审稿人说文章中参考文献引用中国的文章过多而拒稿，同时还说不应该用文章来宣传爱国主义。杂志社采纳了这个意见，给拒稿了。这杂志居然采用了具有国家歧视主义审稿人的意见，这种杂志我们中国人还要投稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/131c98d903b8e5db2b7486caf38332d6.jpg, createdBy=c9991729217, createdName=氢弹, createdTime=Mon Aug 14 23:46:15 CST 2023, time=2023-08-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2122162, encodeId=28df2122162bc, content=我的一篇综述类文章，投完当天状态栏就是Decision in Process，这样的状态3天了，是不是被拒了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50ae70407, createdName=wenan666, createdTime=Mon Mar 27 23:53:39 CST 2023, time=2023-03-27, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=965791, encodeId=24d7965e91cf, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;心血管药理学 经验分享：2020.11.31投稿，2021.1.30修回意见，两个审稿专家，都很nice，也很专业。要求3.15号之前修回，因为没啥大问题所以2.15号就修回了，2.17号接收，2.21号就online 了，速度很快，评审也很严谨，非常nice的投稿，保证了毕业~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=deb55445078, createdName=ms8000000153481283, createdTime=Sat May 15 10:44:43 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913302, encodeId=3f7b913302aa, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：大水刊，黑名单杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=443, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:36:22 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808273, encodeId=71978082e3b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问Required reviews completed这个状态会持续多久呢？ 7.31变成该状态后，8.11更新还是这个状态。是外审结束了吗？编辑大概多久做决定呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf75125321, createdName=二胖十一小同学, createdTime=Wed Aug 12 22:06:39 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587616, encodeId=b8e958e616d5, content=请问，疫情期间审稿周期大概多长时间？这个杂志需要提供原始数据吗？jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, beContent=jiabo322 2020-03-20 00:00:00 发表: 意思是对于你的文章要不要外审，编辑还在考虑中, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be135209757, createdName=14759364m80(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京)]

2024-02-19 Rambo 来自北京

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：中药提取物
经验分享：2月16号投稿
2月18号Decision in Process

21 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务